These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24166280)
1. Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling. Gorczynski RM; Chen Z; Khatri I; Podnos A; Yu K Breast Cancer Res Treat; 2013 Nov; 142(2):271-82. PubMed ID: 24166280 [TBL] [Abstract][Full Text] [Related]
2. Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions. Gorczynski RM; Erin N; Maqbool T; Gorczynski CP; Gorczynski LY Breast Cancer; 2018 Sep; 25(5):547-559. PubMed ID: 29532324 [TBL] [Abstract][Full Text] [Related]
3. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy. Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195 [TBL] [Abstract][Full Text] [Related]
4. Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor. Gorczynski RM; Erin N; Zhu F Cancer Med; 2016 Feb; 5(2):325-36. PubMed ID: 26725371 [TBL] [Abstract][Full Text] [Related]
5. A comparison of serum miRNAs influencing metastatic growth of EMT6 vs 4THM tumor cells in wild-type and CD200R1KO mice. Gorczynski RM; Zhu F; Chen Z; Kos O; Khatri I Breast Cancer Res Treat; 2017 Apr; 162(2):255-266. PubMed ID: 28160157 [TBL] [Abstract][Full Text] [Related]
6. Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6. Podnos A; Clark DA; Erin N; Yu K; Gorczynski RM Breast Cancer Res Treat; 2012 Nov; 136(1):117-27. PubMed ID: 23053647 [TBL] [Abstract][Full Text] [Related]
7. Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice. Gorczynski RM; Clark DA; Erin N; Khatri I Breast Cancer Res Treat; 2011 Nov; 130(1):49-60. PubMed ID: 21165772 [TBL] [Abstract][Full Text] [Related]
8. Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model. Curry A; Khatri I; Kos O; Zhu F; Gorczynski R PLoS One; 2017; 12(2):e0171586. PubMed ID: 28234914 [TBL] [Abstract][Full Text] [Related]
9. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients. Yu K; Chen Z; Gorczynski R Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice. Gorczynski RM; Chen Z; Diao J; Khatri I; Wong K; Yu K; Behnke J Breast Cancer Res Treat; 2010 Sep; 123(2):405-15. PubMed ID: 19953316 [TBL] [Abstract][Full Text] [Related]
12. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response. Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452 [TBL] [Abstract][Full Text] [Related]
13. Anti-CD200R2, anti-IL-9, anti-IL-35, or anti-TGF-β abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice. Gorczynski R; Yu K; Chen Z Transplantation; 2014 Jan; 97(1):39-46. PubMed ID: 24142033 [TBL] [Abstract][Full Text] [Related]
14. A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma. Liu JQ; Talebian F; Wu L; Liu Z; Li MS; Wu L; Zhu J; Markowitz J; Carson WE; Basu S; Bai XF J Immunol; 2016 Aug; 197(4):1489-97. PubMed ID: 27385779 [TBL] [Abstract][Full Text] [Related]
16. CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor. Rygiel TP; Karnam G; Goverse G; van der Marel AP; Greuter MJ; van Schaarenburg RA; Visser WF; Brenkman AB; Molenaar R; Hoek RM; Mebius RE; Meyaard L Oncogene; 2012 Jun; 31(24):2979-88. PubMed ID: 22020332 [TBL] [Abstract][Full Text] [Related]
17. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K. Khan IZ; Del Guzzo CA; Shao A; Cho J; Du R; Cohen AO; Owens DM Cancer Res; 2021 Oct; 81(19):5021-5032. PubMed ID: 34183355 [TBL] [Abstract][Full Text] [Related]
18. Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment. Pilch Z; Tonecka K; Braniewska A; Sas Z; Skorzynski M; Boon L; Golab J; Meyaard L; Rygiel TP Cancer Immunol Res; 2018 Aug; 6(8):930-940. PubMed ID: 30021725 [TBL] [Abstract][Full Text] [Related]
19. Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice. Gorczynski RM; Chen Z; Hu J; Kai Y; Lei J Clin Exp Immunol; 2001 Nov; 126(2):220-9. PubMed ID: 11703364 [TBL] [Abstract][Full Text] [Related]
20. The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies. Pilch Z; Tonecka K; Skorzynski M; Sas Z; Braniewska A; Kryczka T; Boon L; Golab J; Meyaard L; Rygiel TP PLoS One; 2019; 14(1):e0210796. PubMed ID: 30653571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]